ATE504001T1 - Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel - Google Patents

Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel

Info

Publication number
ATE504001T1
ATE504001T1 AT02762796T AT02762796T ATE504001T1 AT E504001 T1 ATE504001 T1 AT E504001T1 AT 02762796 T AT02762796 T AT 02762796T AT 02762796 T AT02762796 T AT 02762796T AT E504001 T1 ATE504001 T1 AT E504001T1
Authority
AT
Austria
Prior art keywords
diagnosing
monitoring
defect
sugar metabolism
gbp28
Prior art date
Application number
AT02762796T
Other languages
English (en)
Inventor
Motowo Tomita
Yasuko Nakano
Hiroshi Hirose
Koichi Matsubara
Original Assignee
Fujirebio Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujirebio Kk filed Critical Fujirebio Kk
Application granted granted Critical
Publication of ATE504001T1 publication Critical patent/ATE504001T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT02762796T 2001-08-17 2002-08-16 Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel ATE504001T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001248047 2001-08-17
PCT/JP2002/008331 WO2003016906A1 (fr) 2001-08-17 2002-08-16 Procede de diagnostic ou de controle d'une erreur du metabolisme du saccharose

Publications (1)

Publication Number Publication Date
ATE504001T1 true ATE504001T1 (de) 2011-04-15

Family

ID=19077272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02762796T ATE504001T1 (de) 2001-08-17 2002-08-16 Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel

Country Status (10)

Country Link
US (2) US7067634B2 (de)
EP (1) EP1426764B1 (de)
JP (1) JP3624216B2 (de)
AT (1) ATE504001T1 (de)
AU (1) AU2002328630B2 (de)
CA (1) CA2459489C (de)
DE (1) DE60239622D1 (de)
DK (1) DK1426764T3 (de)
ES (1) ES2361663T3 (de)
WO (1) WO2003016906A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1607742B1 (de) 2003-03-24 2011-11-23 Mitsubishi Chemical Medience Corporation Latex-reaktionsmittel zur adiponectinanalyse und verfahren zur adiponectinanalyse
JP2006526762A (ja) * 2003-04-29 2006-11-24 サイトス バイオテクノロジー アーゲー アジポネクチンとそのレセプターとの間の相互作用を調節するための方法及び組成物
JP4717810B2 (ja) * 2003-06-20 2011-07-06 ユニバーシティ オブ フロリダ リサーチ ファウンデーション インコーポレイテッド １型糖尿病と２型糖尿病を識別するためのバイオマーカー
US7176292B2 (en) * 2003-09-11 2007-02-13 Dialean, Ltd. Ghrelin variant protein
JP4677545B2 (ja) 2003-10-15 2011-04-27 積水メディカル株式会社 多量体アディポネクチンの分別測定方法
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
EP1684807B1 (de) * 2003-11-07 2009-09-02 Merck & Co., Inc. Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren
WO2005092367A1 (ja) * 2004-03-29 2005-10-06 Fuji Oil Company, Limited アディポネクチン分泌促進組成物
ES2365923T3 (es) 2004-03-31 2011-10-13 Kazuhisa Maeda Uso de adiponectina como marcador en la predicción de infección postoperatoria.
US8563581B2 (en) * 2005-02-02 2013-10-22 Mitos Pharmaceuticals, Inc. Nitroxides for use in treating predisposed or at risk patients
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
CN101932728B (zh) * 2007-11-30 2013-06-19 西门子医疗保健诊断公司 脂连蛋白受体片段和使用方法
WO2010123720A1 (en) 2009-04-23 2010-10-28 Siemens Healthcare Diagnostics Inc. Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
KR20120016117A (ko) 2009-05-07 2012-02-22 오쓰까 세이야꾸 가부시키가이샤 고분자 아디포넥틴 분석을 위한 신규 모노크로날 항체와 그의 이용
JP5048100B2 (ja) 2010-04-28 2012-10-17 シャープ株式会社 アディポネクチンに対する結合性を有するペプチド、ならびに該ペプチドを用いた分析方法および分析装置
RU2553943C1 (ru) * 2014-05-27 2015-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО МГМУ им. И.М. Сеченова) Способ диагностики инсулинорезистентности
CN113454459A (zh) * 2019-02-18 2021-09-28 利物浦大学 诊断方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3538711B2 (ja) * 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
WO2001032868A1 (en) 1999-11-04 2001-05-10 Genset Apm1 biallelic markers and uses thereof

Also Published As

Publication number Publication date
DE60239622D1 (de) 2011-05-12
US7067634B2 (en) 2006-06-27
CA2459489A1 (en) 2003-02-27
EP1426764A1 (de) 2004-06-09
US7435551B2 (en) 2008-10-14
ES2361663T3 (es) 2011-06-21
JP3624216B2 (ja) 2005-03-02
CA2459489C (en) 2010-02-02
JPWO2003016906A1 (ja) 2004-12-02
EP1426764A4 (de) 2005-12-14
US20050266506A1 (en) 2005-12-01
WO2003016906A1 (fr) 2003-02-27
EP1426764B1 (de) 2011-03-30
DK1426764T3 (da) 2011-06-27
AU2002328630B2 (en) 2005-09-01
US20050048565A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
ATE504001T1 (de) Verfahren zur diagnose oder überwachung eines fehlers im zuckerstoffwechsel
De et al. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer’s disease progression
Evans Animal clinical chemistry: a practical handbook for toxicologists and biomedical researchers
EP2124053A1 (de) Verfahren und Gerät zur Erfassung biologischer Informationen und Verfahren und Gerät zur Messung physiologisch aktiver Substanzen
DK1342794T3 (da) Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker
ATE452343T1 (de) Verbesserte vitamin-d-messung
IL193426A0 (en) Methods for the diagnosis of dementia and other neurological disorders
EP2494922A3 (de) Verarbeitung von Analytsensordaten
CA2465800A1 (en) Instrument
WO2010132447A3 (en) Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
DE60025347D1 (de) Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
ATE477497T1 (de) Verfahren zur diagnose von morbus crohn
DE60317379D1 (de) Neurotoxische aminosäure oder neurotoxisches derivat davon im zusammenhang mit neurologischen störungen
US20230266343A1 (en) Methods, Systems & Kits for Prediction, Detection, Monitoring & Treatment of Alzheimer's Disease
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
US20190041407A1 (en) Devices, systems and methods for quantifying hemoglobin s concentration
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
ATE427490T1 (de) Verfahren zur probenvorbehandlung sowie immunologisches testverfahren unter verwendung davon
WO2022212742A3 (en) Anti-ara h 2 antibodies and uses thereof
WO2007015113A3 (en) New protein isoforms of the pif-family and uses thereof
WO2008035204A3 (en) Prediction and prophylactic treatment of type 1 diabetes
WO2009016734A1 (ja) 軽度認知機能障害の検定方法
US20060205024A1 (en) Method to diagnose and evaluate progression of Alzheimer's disease
Curran et al. Uncovering factors related to pancreatic beta-cell function

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties